Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced / Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03138083
What this trial is testing

OMO-1 in Solid Malignancies

Who this might be right for
Neoplasms
Octimet Oncology N.V. 40
Not applicableEnded earlyNCT01190241
What this trial is testing

Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study

Who this might be right for
Advanced Solid TumorsInoperableMetastasis
Amsterdam UMC, location VUmc 45
Early research (Phase 1)Ended earlyNCT05490043
What this trial is testing

A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorMature B-cell Non-Hodgkin Lymphoma
Antengene (Hangzhou) Biologics Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT06880549
What this trial is testing

MRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
ModernaTX, Inc. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06435455
What this trial is testing

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation
Suzhou Genhouse Bio Co., Ltd. 126
Very early researchNot Yet RecruitingNCT07182435
What this trial is testing

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor Malignancies
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 36
Early research (Phase 1)Study completedNCT02884726
What this trial is testing

Phase 1 Study of Mesothelin-ADC

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 8
Early research (Phase 1)Study completedNCT01922752
What this trial is testing

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc. 32
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623707
What this trial is testing

FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
FutureGen Biopharmaceutical (Beijing) Co., Ltd 264
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Early research (Phase 1)Looking for participantsNCT06761651
What this trial is testing

TAVO412 in Patients with Cancer (TAVO412)

Who this might be right for
Cancer
Tavotek Biotherapeutics 50
Early research (Phase 1)Study completedNCT01238939
What this trial is testing

Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

Who this might be right for
Advanced Solid TumorsMetastatic Colorectal Cancer
Nippon Kayaku Co., Ltd. 35
Not applicableStudy completedNCT04889144
What this trial is testing

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Early research (Phase 1)Looking for participantsNCT06963281
What this trial is testing

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Who this might be right for
Solid Tumors
Fortvita Biologics (USA)Inc. 285
Early research (Phase 1)Study completedNCT04134312
What this trial is testing

Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

Who this might be right for
Solid Metastatic Tumor
Bavarian Nordic 13
Early research (Phase 1)Study completedNCT00692159
What this trial is testing

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

Who this might be right for
Neoplasm
Tracon Pharmaceuticals Inc. 28
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Next Page